INS and cancer: In summary, metformin induced favorable regulation of cancer- and metastasis-related genes and proteins in the present study and was able to reduce or cancel negative insulin-induced effects, particularly in a normoglycemic environment, which could be relevant for prediabetic patients with insulin resistance.